|
|
Volumn 133, Issue 12, 2000, Pages 1021-1024
|
|
Developments in cervical and ovarian cancer screening: Implications for current practice
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
LYSOPHOSPHATIDIC ACID;
MONOCLONAL ANTIBODY;
TUMOR MARKER;
ADULT;
AGED;
CANCER RISK;
CANCER SCREENING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GENE MUTATION;
GYNECOLOGIC CANCER;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OVARY CANCER;
PAPANICOLAOU TEST;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SEXUAL BEHAVIOR;
TRANSVAGINAL ECHOGRAPHY;
UTERINE CERVIX CANCER;
UTERINE CERVIX CYTOLOGY;
|
|
EID: 0034687828
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-133-12-200012190-00101 Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|